Evidence map›Paper›PMID 30992692›Full record

ArticleCancer cell international2019

Cross-talk between ER stress and mitochondrial pathway mediated adriamycin-induced testicular toxicity and DA-9401 modulate adriamycin-induced apoptosis in Sprague-Dawley rats.

Keshab Kumar Karna, Bo Ram Choi, Jae Hyung You, Yu Seob Shin, Kiran Kumar Soni, Wan Shou Cui, Sung Won Lee, Chul Young Kim, Hye Kyung Kim, Jong Kwan Park

Open access · goldAbstract read
In one paragraph

Article in Cancer cell international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. mSystems · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Schisandrol A and gomisin N fromNutrition research and practice · 2023
    Article
  8. Distinct Role ofPharmaceuticals (Basel, Switzerland) · 2023
    Review
  9. Article
  10. The hydrogen storage nanomaterial MgHBiomaterials research · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Effects ofFrontiers in pharmacology · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Keshab Kumar Karna1Department of Urology, Institute for Medical Sciences, Chonbuk National University Medical School-Biomedical Research and Institute and Clinical Trial Center for Medical Devices, Chonbuk National University Hospital, Jeonju, 54907 Republic of Korea.
Bo Ram Choi1Department of Urology, Institute for Medical Sciences, Chonbuk National University Medical School-Biomedical Research and Institute and Clinical Trial Center for Medical Devices, Chonbuk National University Hospital, Jeonju, 54907 Republic of Korea.
Jae Hyung You1Department of Urology, Institute for Medical Sciences, Chonbuk National University Medical School-Biomedical Research and Institute and Clinical Trial Center for Medical Devices, Chonbuk National University Hospital, Jeonju, 54907 Republic of Korea.
Yu Seob Shin1Department of Urology, Institute for Medical Sciences, Chonbuk National University Medical School-Biomedical Research and Institute and Clinical Trial Center for Medical Devices, Chonbuk National University Hospital, Jeonju, 54907 Republic of Korea.
Kiran Kumar Soni2Department of Physiology & Biophysics, University of Mississippi Medical Center, Jackson, MS 39216 USA.
Wan Shou Cui3Andrology Center, Peking University First Hospital, Beijing, People's Republic of China.
Sung Won Lee4Department of Urology, Samsung Medical Center, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Seoul, 06351 Republic of Korea.
Chul Young Kim5College of Pharmacy, Hanyang University, Ansan, 426-791 Republic of Korea.
Hye Kyung Kim6College of Pharmacy, Kyungsung University, Busan, 48434 Republic of Korea.
Jong Kwan Park1Department of Urology, Institute for Medical Sciences, Chonbuk National University Medical School-Biomedical Research and Institute and Clinical Trial Center for Medical Devices, Chonbuk National University Hospital, Jeonju, 54907 Republic of Korea.ORCID 0000-0001-9682-2081
Jeonbuk National University Hospital · KRHanyang University · KRJackson Memorial Hospital · USKyungsung University · KRPeking University · CNSamsung Medical Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDA-9401 was prepared as a mixture of Chinese medicinal herb extracts from roots of Morinda officinalis How (Rubiaceae), outer scales of

methodsFifty healthy 8-week-old male Sprague-Dawley rats were equally divided into five groups. The first CTR group was treated with normal saline 2 ml/day by gavage. The second was treated with DA-100 (DA-9401 100 mg/kg/day). The third (ADR) group received ADR (2 mg/kg/once a week) intraperitoneally, while the combination of ADR and DA-9401 was given to the fourth ADR + DA-100 (100 mg/kg/day p.o) group and fifth ADR + DA-200 (200 mg/kg/day p.o) group. At the end of the 8-week treatment period, body weight, reproductive organ weights, fertility rate, pups per female were recorded, and serum were assayed for hormone concentrations. Tissues were subjected to semen analysis, histopathological changes, interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), oxidative stress markers and expression levels of endoplasmic reticulum (ER) stress markers, apoptosis markers, tight junction protein markers, steroidogenic acute regulatory protein (StAR), cation channel of sperm (CatSper) and glycogen synthase kinase-3 (GSK-3) by western blot.

resultsDA-9401 administration to ADR-treated rats significantly decreased serum luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels, interleukin-6, TNF-α, MDA level, ROS/RNS level, ER stress response protein levels, tunnel positive cells, cleaved caspase-3, and Bax/Bcl2 ratio. Moreover, pretreatment with DA-9401 significantly increased body weight, reproductive organ weights, fertility rate, pups per female, Johnsen's score, spermatogenic cell density, sperm count and sperm motility, serum testosterone concentration, testicular superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), tight junction protein markers, star protein level, CatSper, and GSK-3 level.

conclusionsADR treatment can markedly impair testicular function and induce testicular cell death presumably by causing significant changes in oxidative stress, ER stress, and mitochondrial pathway. DA-9401 exerts beneficial effects against oxidative stress, ER stress, and mitochondria-mediated cell death pathway in testis tissue by up-regulating expression levels of tight junction protein markers, steroidogenic acute regulatory protein, GSK-3 alpha, and cation channels of sperm.

Indexed as

Adriamycin (ADR)ApoptosisBlood-testis barrier (BTB)Cation channel of sperm (CatSper)DA-9401Endoplasmic reticulum (ER) stressGlycogen synthase kinase-3 (GSK-3)Oxidative stressSteroidogenic acute regulatory protein (StAR)

Identifiers

PMID30992692
PMCPMC6450013
OpenAlexW2943865098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.